Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Östensson E) "

Sökning: WFRF:(Östensson E)

  • Resultat 1-10 av 12
  • [1]2Nästa
Sortera/gruppera träfflistan
  • Eriksson, T., et al. (författare)
  • Sibbaldia: a molecular phylogenetic study of a remarkably polyphyletic genus in Rosaceae
  • 2015
  • Ingår i: Plant Systematics and Evolution. - 0378-2697 .- 1615-6110. ; 301:1, s. 171-184
  • Tidskriftsartikel (refereegranskat)abstract
    • Using DNA sequence data from nuclear ribosomal ITS in combination with plastid trnLF spacer and trnL intron data, we show that Sibbaldia is a polyphyletic assemblage. It falls into five separate clades of Potentilleae, three within Fragariinae and two within Potentilla (Potentillinae sensu Sojak). To a large extent, our results are congruent with Sojak's findings based on morphological characters such as anther structure. Four of the Sibbaldia species included in this study remain in Sibbaldia, while S. adpressa is classified in Sibbaldianthe, S. perpusilloides is considered to represent a new genus in Fragariinae, Chamaecallis Smedmark, S. micropetala is nested within the Potentilla anserina clade, and four species belong to a basal clade of Potentilla. The phylogenetic affinity of Sibbaldiopsis is still unsettled, but one of the three species that have been classified in the genus is found to belong inside Sibbaldia, and it should be named Sibbaldia retusa (O.F. Muller) T. Erikss. Further study will show whether the remaining two species, Potentilla cuneifolia and P. miyabei, are more closely related to Sibbaldia, Sibbaldianthe, or if they make up a distinct lineage separate from either of these.
  • Andersson, Sonia, et al. (författare)
  • Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results : Promising Opportunity for Specific Cancer Education
  • 2019
  • Ingår i: Journal of Cancer Education. - : Springer. - 0885-8195 .- 1543-0154.
  • Tidskriftsartikel (refereegranskat)abstract
    • This study aims to investigate acceptance of vaginal self-sampling for high-risk human papilloma virus (HPV) among long-term screening non-attenders at increased cervical cancer risk and to identify leverage points to promote screening adherence among these women. Forty-three long-term screening non-attenders performed home vaginal self-sampling for HPV, had positive HPV results, and subsequently attended gynecologic examination. Sixteen (37.2%) had high-grade cervical intraepithelial neoplasia (CIN2 or 3), and two had invasive cervical cancer. Forty-one of these women completed a questionnaire concerning Specific Knowledge about HPV, CIN, and cervical cancer, potential barriers to screening and views about self-sampling. Results were compared with 479 women treated for CIN2+ who attended gynecologic follow-up and also performed self-sampling. Significant multivariate predictors of long-term non-attender status compared with referents were low Specific Knowledge, high confidence in self-sampling, and potential barriers-refraining from activity to attend gynecologic examination, needing another's help to attend, and long travel time. Non-attenders citing fear/refraining from gynecologic examination as why they preferred self-sampling significantly more often had lowest Specific Knowledge compared with other non-attenders. All non-attenders could envision themselves doing self-sampling again while only 74% of referents endorsed this statement (p = 0.0003). We conclude that HPV self-sampling is an acceptable option for women at increased cervical cancer risk who have been long-term screening non-attenders. Educational outreach to enhance Specific Knowledge about HPV, CIN and cervical cancer is critical. Those non-attenders who explicitly avoid gynecologic examinations need special attention. Trial Registry: Clinicaltrials.gov NCT02750124.
  • Pandey, Gaurav Kumar, et al. (författare)
  • The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.
  • 2014
  • Ingår i: Cancer Cell. - 1535-6108 .- 1878-3686. ; 26:5, s. 722-737
  • Tidskriftsartikel (refereegranskat)abstract
    • Neuroblastoma is an embryonal tumor of the sympathetic nervous system and the most common extracranial tumor of childhood. By sequencing transcriptomes of low- and high-risk neuroblastomas, we detected differentially expressed annotated and nonannotated long noncoding RNAs (lncRNAs). We identified a lncRNA neuroblastoma associated transcript-1 (NBAT-1) as a biomarker significantly predicting clinical outcome of neuroblastoma. CpG methylation and a high-risk neuroblastoma associated SNP on chromosome 6p22 functionally contribute to NBAT-1 differential expression. Loss of NBAT-1 increases cellular proliferation and invasion. It controls these processes via epigenetic silencing of target genes. NBAT-1 loss affects neuronal differentiation through activation of the neuronal-specific transcription factor NRSF/REST. Thus, loss of NBAT-1 contributes to aggressive neuroblastoma by increasing proliferation and impairing differentiation of neuronal precursors.
  • Razumova, Z., et al. (författare)
  • The prognostic role of LRIG proteins in endometrial cancer
  • 2019
  • Ingår i: International Journal of Gynecological Cancer. - : BMJ Publishing Group Ltd. - 1048-891X .- 1525-1438. ; 29, s. A358-A358
  • Tidskriftsartikel (övrigt vetenskapligt)abstract
    • Introduction/Background Endometrial cancer (EC) is the most common gynaecological malignancy in Sweden. The disease has several prognostic factors. Still, the high amount of EC develops into more aggressive forms of cancer, even though being first considered to be non-aggressive. The LRIG proteins are a family of three integral surface proteins that have a similar domain organisation. The current study evaluated the role of LRIG proteins as prognostic biomarkers in EC.Methodology The cohort included 75 women who underwent a hysterectomy and bilateral salpingo-oophorectomydue to EC at the Department of Women's and Children's Health, Karolinska University Hospital Solna between 2007 and 2012. The expression of LRIG1, LRIG2, and LRIG3 in paraffin biopsies was analysed by immunohistochemistry (IHC) with applying specific polyclonal antibodies. Evaluation of immunostainings was performed by two senior pathologists without knowledge of the disease outcome. The percentage of positive cells was divided in two groups with median percentage as cut off to have two groups of equal size included in the statistical analysis. Then the groups were assessedin connection with different tumour characteristics and clinical outcomes of EC.Results The majority of women in the cohort had >50% LRIG1-, LRIG2-, and LRIG3-positive cells. Among 6047 person-months of follow-up a total, of 14 incident cases of relapsed EC were identified. A statistically significant association between high LRIG3 expression and superior overall survival was observed in the cohort (IRR=2.559, 95 CI=1.054–6.210, p=0.038). LRIG1 and LRIG2 expression did not significantly correlate with survival.Conclusion Our results support the hypothesis that LRIG3 expression may have a prognostic role in women with EC. The significance of LRIG1 and LRIG2 expression remains to be clarified.
  • Aarnio, Riina, 1971-, et al. (författare)
  • Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study
  • 2020
  • Ingår i: ; 20:1
  • Tidskriftsartikel (övrigt vetenskapligt)abstract
    • BackgroundHuman papillomavirus (HPV) testing is recommended in primary cervical screening to improve cancer prevention. An advantage of HPV testing is that it can be performed on self-samples, which could increase population coverage and result in a more efficient strategy to identify women at risk of developing cervical cancer. Our objective was to assess whether repeated self-sampling for HPV testing is cost-effective in comparison with Pap smear cytology for detection of cervical intraepithelial neoplasia grade 2 or more (CIN2+) in increasing participation rate in primary cervical screening.MethodsA cost-effectiveness analysis (CEA) was performed on data from a previously published randomized clinical study including 36 390 women aged 30–49 years. Participants were randomized either to perform repeated self-sampling of vaginal fluid for HPV testing (n = 17 997, HPV self-sampling arm) or to midwife-collected Pap smears for cytological analysis (n = 18 393, Pap smear arm).ResultsSelf-sampling for HPV testing led to 1633 more screened women and 107 more histologically diagnosed CIN2+ at a lower cost vs. midwife-collected Pap smears (€ 228 642 vs. € 781 139). ConclusionsThis study projected that repeated self-sampling for HPV testing increased participation and detection of CIN2+ at a lower cost than midwife-collected Pap smears in primary cervical screening. Offering women a home-based self-sampling may therefore be a more cost-effective alternative than clinic-based screening. 
  • Mansor, Fazliana, et al. (författare)
  • Labisia pumila Upregulates Peroxisome Proliferator-Activated Receptor Gamma Expression in Rat Adipose Tissues and 3T3-L1 Adipocytes.
  • 2013
  • Ingår i: Advances in Pharmacological Sciences. - 1687-6334 .- 1687-6342. ; :Article ID 808914
  • Tidskriftsartikel (refereegranskat)abstract
    • Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor that regulates lipid and glucose metabolism. We investigated the effects of Labisia pumila (LP) standardized water extract on PPARgamma transcriptional activity in adipocytes in vitro and in vivo. We used a rat model of dihydrotestosterone- (DHT-) induced polycystic ovary syndrome (PCOS), a condition characterized by insulin resistance. At 9 weeks of age, the PCOS rats were randomly subdivided into two groups: PCOS-LP (50 mg/kg/day of LP) and PCOS-control (1 mL of deionised water) for 4-5 weeks on the same schedule. Real-time RT-PCR was performed to determine the PPARgamma mRNA levels. LP upregulated PPARgamma mRNA level by 40% in the PCOS rats. Western blot analysis further demonstrated the increased PPARgamma protein levels in parallel with upregulation in mRNA. These observations were further proven by adipocytes culture. Differentiated 3T3-L1 adipocytes were treated with final concentration of 100  μ g/mL LP and compared to untreated control and 10  μ M of rosiglitazone (in type of thiazolidinediones). LP increased PPARgamma expressions at both mRNA and protein levels and enhanced the effect of glucose uptake in the insulin-resistant cells. The data suggest that LP may ameliorate insulin resistance in adipocytes via the upregulation of PPARgamma pathway.
  • Ranhem, Cecilia, et al. (författare)
  • Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
  • 2017
  • Ingår i: ; 12:8
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Primary vaginal carcinoma (PVC) is a rare malignancy. Established prognostic factors include tumour stage and age at diagnosis. The leucine-rich repeats and immunoglobuline-like domains (LRIG)-1 protein functions as a tumour suppressor, but less is known about the functions of LRIG2 and LRIG3. The present study aimed to evaluate the expression of LRIG proteins and analyse their possible associations with clinical characteristics and survival in a cohort of PVC patients.Methods: We used immunohistochemistry to investigate LRIG1, LRIG2, and LRIG3 expression in tumour samples from a consecutive cohort of 70 PVC patients. The association between LRIG protein expression and clinical characteristics and cancer-specific survival was investigated using univariate and multivariate analyses.Results: The majority of PVC patients (72%) had >50% LRIG1- and LRIG2-positive cells, and no or low LRIG3-positive cells. HPV status was significantly correlated with LRIG1 expression (p = 0.0047). Having high LRIG1 expression was significantly correlated with superior cancer-specific survival in univariate and multivariate analyses. LRIG2 and LRIG3 expression did not significantly correlate with clinical characteristics or survival.Conclusion: LRIG1 expression might be of interest as a prognostic marker in PVC patients, whereas the role of LRIG2 and LRIG3 expression remains to be clarified.
  • Silfverschiöld, Maria, et al. (författare)
  • Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite
  • Ingår i: PLoS ONE. - : Public Library of Science. - 1932-6203. ; 14:7
  • Tidskriftsartikel (refereegranskat)abstract
    • Background The incidence of oropharyngeal cancer (OPC) is increasing, particularly human papillomavirus (HPV)-associated OPC. The aim of this study was to specify the total societal cost of OPC by HPV status, cancer stage, and subsite using a bottom-up cost-of-illness approach. Methods We analyzed 121 consecutive patients with OPC from the Southern Health Care Region of Sweden. We estimated the direct medical costs and indirect costs (e.g., disease-related morbidity and premature death) from 1 month prior to OPC diagnosis until 3 years after treatment completion. Results The mean total cost per patient was 103 386 for HPV-positive and 120 244 for HPV-negative OPC. Eighty-one percent of the patients analyzed were HPV-positive: Accordingly, HPV-positive OPC represented 79% of the total cost of OPC. The mean total cost of stage I, II, III, IVA, IVB, and IVC, regardless of HPV status, was 59 424, 57 000, 69 246, 115 770, 234 459, and 21 930, respectively, of which indirect costs were estimated at 22 493 (37.8%), 14 754 (25.9%), 28 681 (41.4%), 67 107 (58%), 166 280 (70.9%), and 0. Tonsillar cancer represented 64% of OPC, with a mean total cost of 117 512 per patient. Conclusion The societal cost of OPC is substantial. HPV-associated OPC comprises 79% of the total cost of this disease. The data presented in this study may be used in analytical models to aid decision makers in determining the potential value of gender-neutral HPV vaccination.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 12
  • [1]2Nästa
Typ av publikation
tidskriftsartikel (12)
Typ av innehåll
refereegranskat (10)
övrigt vetenskapligt (2)
Ostensson, E (6)
Östensson, Ellinor (5)
Greiff, Lennart (2)
Andersson, S (2)
Mints, M (2)
Aarnio, Riina, 1971- (1)
visa fler...
Gustavsson, Inger M. (1)
Gyllensten, Ulf B. (1)
Olovsson, Matts, 195 ... (1)
Gyllensten, U (1)
Gustavsson, I (1)
Aarnio, R (1)
Olovsson, M (1)
Töpel, Mats H., 1973 (1)
Töpel, Mats (1)
Kogner, Per (1)
Nilsson, Staffan, 19 ... (1)
Kogner, P (1)
Nilsson, S (1)
Martinsson, Tommy, 1 ... (1)
Martinsson, T (1)
Abrahamsson, Jonas, ... (1)
Abrahamsson, J (1)
Fransson, Susanne, 1 ... (1)
Larsson, E G (1)
Larsson, E (1)
Gu, HF (1)
Mitra, S. (1)
Adamovic, Svetlana, ... (1)
Gudjonsdottir, Audur ... (1)
Ascher, Henry, 1953 (1)
Ek, Johan (1)
Torinsson Naluai, Ås ... (1)
Wahlström, Jan, 1939 (1)
Gronberg, H (1)
Eriksson, T (1)
Agardh, Daniel (1)
Agardh, D. (1)
Wahlstrom, J (1)
Kanduri, Chandrasekh ... (1)
Kanduri, C (1)
Hellman, K (1)
Larsson, Erik, 1975 (1)
Sparén, Pär (1)
Sparen, P (1)
Akyürek, Levent, 196 ... (1)
Akyurek, LM (1)
Bandaru, Sashidar (1)
Bandaru, S (1)
visa färre...
Karolinska Institutet (7)
Göteborgs universitet (4)
Umeå universitet (2)
Lunds universitet (2)
Uppsala universitet (2)
Örebro universitet (2)
visa fler...
Stockholms universitet (1)
Högskolan i Skövde (1)
Naturhistoriska riksmuseet (1)
visa färre...
Engelska (12)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (8)
Naturvetenskap (4)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy